Published 2019-07-02
Prayoga Triyadi Kurnia Putra Septa Surya Wahyudi Ancah Caesarina Novi M


Objective: Benign Prostatic Hyperplasia (BPH) is a benign tumor located in prostate caused by prostate cell that will continuously grows which covalent with the aging process and the dihidrotestosteron level (DHT) increase. Prostate Hyperplasia can stop the urethra pars prostatics and causesa clogging in the urine’s flow excretes from bladder. Lower Urinary Tract Symptomps (LUTS) is a bladder muscle compensation mechanism to excrete urine. Diabetes Mellitus (DM) is one of the risk factors of BPH. This research aimed to find the differences on the degree of severity and quality of life BPH DM with BPH non-DM. Material & Methods: This research was observational analytic with cross sectional design which done to 32 subjects that consist of 16 BPH-DM subjects and 16 BPH non-DM in Bina Sehat Hospital Jember, Paru Hospital Jember, and Bhayangkara Hospital Bondowoso which meet to the inclusion and exclusion criteria. Data acquired from lead interview result using International Prostate Symptoms Score (IPSS) questionnaire to evaluate the degree of severity and World Health Organization Quality of Life (WHOQOL-BREF) questionnaire to evaluate the quality of life. The data processing using Mann Whitney’s comparative test. Results: IPSS and physic domain, psychology and social had p value in a row 0.001; 0.000; 0.001; and 0.001. Conclusion: It showed that there was a meaningful difference between BPH DM with BPH non-DM. Environment domain had p value of 0.373. It showed the non-meaningful difference between BPH DM with BPH non-DM.



Benign prostate hyperplasia, diabetes mellitus, international prostate symptoms score, world health organization quality of life


Kapoo A. Benign prostatic hyperplasia (BPH) management in the primary care setting. Canada: Department of Urology McMaster University; 2012.

Indonesian Urological Association. Panduan penatalaksanaan klinis pembesaran prostat jinak (Benign Prostatic Hyperplasia/BPH); 2015.

Gloria S, Monoarfa RA, Salem B. Angka kejadian LUTS yang disebabkan oleh BPH di RSUP Prof. Dr. dr. R.D. Kandou Manado periode 2009-2013. Jurnal e-Clinic (eCl). 2015; 3(1): 568-72.

Purnomo BB. Dasar-dasar urologi, 3rd ed. Malang; 2014.

American Diabetes Association. Position statement: Standards of medical care in Diabetes. Diab Care. 2016; 39: 33(Suppl. 1).

International of Diabetic Federation. IDF clinical guidelines task force. Global Guideline for Type 2 Diabetes. Brussels; 2015.

Michel MC, Mehlburger L, Schumacher H, Bressel HU, Goepel M. Effect of diabetes on lower urinary tract symptomps in patients with benign prostatic hyperplasia. American Urology Association. 2010; 163.

Woo JB, Joo YL, Kyo CK, Yoon SH, Dae HL, Kang SC. Prostatic disease and male voiding dysfunction. Is type-2 diabetes mellitus associated with overactive bladder symptoms in men with lower urinary tract symptoms?. Gangnam-gu, Seoul. Journal of Urology; 2014.

Aruna VS, Parsons JK. Diabetes and benign prostatic hyperplasia: Emerging clinical connections. Curr Urol Rep. 2009; 10: 4.

Eom CS, Park JH, Cho BL. Metabolic syndrome and accompanying hyperinsulinemia have favorable effects on lower urinary tract symptoms in a generally healthy screened population. J Urol. 2011; 186: 175-9.

Burke JP, Jacobson DJ, McGree ME, Roberts RO, Girman CJ, Lieber MM, et al. Diabetes and benign prostatic hyperplasia progression in Olmsted County. Minnesota. Urol. 2006 ;67(1): 225.

Rohrmann S, Smit E, Giovannucci E. Association between markers of the metabolic syndrome and lower urinary tract symptoms in the third national health and nutrition examination survey (NHANES III). Int J Obesity. 2005; 29: 310.

Welch G, Weinger B, Michael J. Quality of life impact of lower urinary tract symptom severity: Results from the health professionals follow-up study. Urology. 2002. 59; 245-50.

Gacci M, Bartoletti R, Figlioli SE, Boddi R. Urinary symptoms, quality of life and sexual function in patients with benign prostate hyperplasia before and after prostatectomy: A Prospective Study. BJU International. 2003; 91: 196-200.

Haltbakk J, Hanestad BR, Hunskaar S. How important are men’s lower urinary tract symptomps (LUTS) and their impact on the quality of life (QOL)? Quality of Life Research. 2005; 14: 1733-41.

Anbarasan SS. Gambaran kualitas hidup lansia dengan hipertensi di wilayah kerja puskesmas rendang pada periode 27 februari. ISM. 2015; 4(1): 113-24.

Hawthorne G, Herman H, Murphy B. Interpreting the WHOQOL-BREF: Pelminary population norm and effect sizes. Social Indicators Research. 2006; 77: 35-37.

Copyright Information
Department of Urology, Faculty of Medicine/Airlangga University